Nov 17, 2023 · a u. s. Shortage of the new generic version of vyvanse, an adhd medication, is due in part to federal limits on production, according to an industry group representing generic. Nov 1, 2024 · soon after vyvanse’s patent expired in 2023, applications for generic formulations of lisdexamfetamine dimesylate started flowing into the fda. There are now 18 approved.
The McKinley Richardson Leak: The Truth Hurts
The Video Leak: Pamibaby's Defining Moment
The Morgan Vera Leak: The Investigation Continues